Agilent Technologies (A) Net Cash Flow Growth (3y) (2012 - 2026)
Agilent Technologies (A) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | 89.23% |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | 138.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 41.14% |
| Jan 31, 2026 | -31.40% |
| Oct 31, 2025 | 343.10% |
| Jul 31, 2025 | 34.46% |
| Apr 30, 2025 | -28.20% |
| Jan 31, 2025 | 34.34% |
| Oct 31, 2024 | -113.44% |
| Jul 31, 2024 | 27.62% |
| Apr 30, 2024 | -49.09% |
| Jan 31, 2024 | 48.12% |
| Oct 31, 2023 | 50.30% |
| Jul 31, 2023 | 77.50% |
| Apr 30, 2023 | -38.62% |
| Jan 31, 2023 | 46.26% |
| Oct 31, 2022 | 80.12% |
| Jul 31, 2022 | 34.67% |
| Apr 30, 2022 | -6.87% |
| Jan 31, 2022 | -22.97% |
| Oct 31, 2021 | -22.99% |
| Jul 31, 2021 | 27.22% |